Literature DB >> 18574159

Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery.

Karl Y Bilimoria1, David J Bentrem, Joseph M Feinglass, Andrew K Stewart, David P Winchester, Mark S Talamonti, Clifford Y Ko.   

Abstract

PURPOSE: Quality-improvement initiatives are being developed to decrease volume-based variability in surgical outcomes. Resources for national and hospital quality-improvement initiatives are limited. It is unclear whether quality initiatives in surgical oncology should focus on factors affecting perioperative mortality or long-term survival. Our objective was to determine whether differences in hospital surgical volume have a larger effect on perioperative mortality or long-term survival using two methods. PATIENTS AND METHODS: From the National Cancer Data Base, 243,103 patients who underwent surgery for nonmetastatic colon, esophageal, gastric, liver, lung, pancreatic, or rectal cancer were identified. Multivariable modeling was used to evaluate 60-day mortality and 5-year conditional survival (excluding perioperative deaths) across hospital volume strata. The number of potentially avoidable perioperative and long-term deaths were calculated if outcomes at low-volume hospitals were improved to those of the highest-volume hospitals.
RESULTS: Risk-adjusted perioperative mortality and long-term conditional survival worsened as hospital surgical volume decreased for all cancer sites, except for liver resections where there was no difference in survival. When comparing low- with high-volume hospitals, the hazard ratios for perioperative mortality were substantially larger than for long-term survival. However, the number of potentially avoidable deaths each year in the United States, if outcomes at low-volume hospitals were improved to the level of highest-volume centers, was significantly larger for long-term survival.
CONCLUSION: Although the magnitude of the hazard ratios implies that quality-improvement efforts should focus on perioperative mortality, a larger number of deaths could be avoided by focusing quality initiatives on factors associated with long-term survival.

Entities:  

Mesh:

Year:  2008        PMID: 18574159     DOI: 10.1200/JCO.2007.15.6356

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  49 in total

1.  Improving lung cancer outcomes by improving the quality of surgical care.

Authors:  Raymond U Osarogiagbon; Thomas A D'Amico
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  The Multidisciplinary Management of Cancer in Daily Clinical Practice: Towards a Community Hospital Comprehensive Cancer Center.

Authors:  Jacopo Giuliani; Andrea Bonetti
Journal:  J Gastrointest Cancer       Date:  2016-03

3.  Reducing the Time From Diagnosis to Treatment of Patients With Stage II/III Rectal Cancer at a Large Public Hospital.

Authors:  Marc S Hoffmann; Lori A Leslie; Ryan W Jacobs; Stefanos Millas; Venkateswar Surabhi; Henry Mok; Pavan Jhaveri; Marylee M Kott; Lymesia Jackson; Alyssa Rieber; Nishin A Bhadkamkar
Journal:  J Oncol Pract       Date:  2016-02       Impact factor: 3.840

4.  How does extended lymphadenectomy influence practical care for patients with gastric cancer?

Authors:  Ilfet Songun; Cornelis J H van de Velde
Journal:  Nat Clin Pract Oncol       Date:  2008-12-17

Review 5.  The volume effect in liver surgery--a systematic review and meta-analysis.

Authors:  Arthur J Richardson; Tony C Y Pang; Emma Johnston; Michael J Hollands; Vincent W T Lam; Henry C C Pleass
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

6.  Accomplishments in 2008 in the management of esophageal cancer.

Authors:  Gary Y Yang; Katja Ott
Journal:  Gastrointest Cancer Res       Date:  2009-09

Review 7.  Should esophageal resections for cancer be performed in high-volume centers only?

Authors:  Carlo V Feo; Victoria M Villaflor; Marco G Patti
Journal:  Updates Surg       Date:  2011-06-22

8.  Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC).

Authors:  Mariangela Desantis; Jean-Louis Bernard; Vincent Casanova; Marianne Cegarra-Escolano; Emmanuel Benizri; Amine M Rahili; Daniel Benchimol; Jean-Marc Bereder
Journal:  Langenbecks Arch Surg       Date:  2014-10-16       Impact factor: 3.445

9.  One, two, three or four ports… does it matter? Priorities in lung cancer surgery.

Authors:  Herbert Decaluwé
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

10.  Socioeconomic disparities in breast cancer survival: relation to stage at diagnosis, treatment and race.

Authors:  Xue Qin Yu
Journal:  BMC Cancer       Date:  2009-10-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.